- Shopping Bag ( 0 items )
From The CriticsReviewer: Barbara L Giacomelli, PharmD., MBA (McKesson Provider Technologies)
Description: This manual defines and outlines regulatory agencies, regulations, and reporting requirements for pharmacovigilance in the United States and other key countries.
Purpose: A goal of the book is to improve medication safety, and it provides a broad overview of how adverse events are handled from discovery through investigation and outcome.
Audience: Written for both practitioners and students, the book is relevant for those in pharmacy, quality assurance, and nursing. The author is hoping to increase practitioners' knowledge and motivate them to improve drug safety.
Features: The book is very detailed. It defines drug safety and adverse drug events, and it is an excellent guide to the different regulatory agencies that oversee medication therapy in the United States and other countries. It provides information on medications from research and approval to post-marketing surveillance and ongoing monitoring.
Assessment: This manual is useful as a tool for education in pharmacy schools and as a resource for pharmacy quality management. It is the most comprehensive reference I have seen on pharmacovigilance.